Placental Growth Factor: a Novel, Stromal-Derived Target in Human CML.
Sonja Loges(German Cancer Research Center), Peter Carmeliet(Khalifa University of Science and Technology), Bart Jonckx(VIB-KU Leuven Center for Cancer Biology), Tim H. Brümmendorf(National University Cancer Institute, Singapore), Tessa L. Holyoake(Gartnavel General Hospital), Jan Cools(KU Leuven), Christa Maes(KU Leuven), Geert Carmeliet(KU Leuven), Kim De Keersmaecker(VIB-KU Leuven Center for Cancer Biology), Peter Vandenberghe(KU Leuven), Karolien Beel(KU Leuven), Thomas Schmidt(Paul Scherrer Institute), Thomas Schenk(Heidelberg University), Marc Tjwa, Christiane Dewolf-Peeters(KU Leuven), Maria Kleppe(Memorial Sloan Kettering Cancer Center), Andreas Hochhaus(Jena University Hospital)
Cited by 2
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k